• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放线菌扩大培养以生产抗菌药物诺卡硫辛。

Actinomycetes scale-up for the production of the antibacterial, nocathiacin.

作者信息

Junker Beth, Walker Andre, Hesse Michelle, Lester Mike, Christensen Jens, Connors Neal

机构信息

Fermentation Development and Operations, Bioprocess Research and Development, Merck Research Laboratories, Rahway, NJ 07065, USA.

出版信息

Biotechnol Prog. 2009 Jan-Feb;25(1):176-88. doi: 10.1002/btpr.122.

DOI:10.1002/btpr.122
PMID:19205044
Abstract

An Amycolatopsis fastidiosa culture, which produces the nocathiacin class of antibacterial compounds, was scaled up to the 15,000 L working volume. Lower volume pilot fermentations (600, 900, and 1,500 L scale) were conducted to determine process feasibility at the 15,000 L scale. The effects of inoculum volume, impeller tip speed, volumetric gas flow rate, superficial gas velocity, backpressure, and sterilization heat stress were examined to determine optimal scale-up operating conditions. Inoculum volume (6 vs. 2 vol %) and medium sterilization (R(o) of 68 vs. 92 min(-1)) had no effect on productivity or titer, and higher impeller tip speeds (2.1 vs. 2.9 m/s) had a slight effect (20% decrease). In contrast, higher backpressure, incorporating increased head pressure at the 15,000 L scale (1.2 vs. 0.7 kg/cm(2)) and low gas flow rates (0.25 vs. 0.8 vvm), appeared to be problematic (40-50% decrease). High off-gas CO2 levels were likely reasons for observed lower productivity. Consequently, air flow rate for this 25-fold scale-up (600-15,000 L) was controlled to match off-gas CO2 profiles of acceptable smaller scale batches to maintain levels below 0.5%. The 15,000 L-scale fermentation achieved an expected nocathiacin I titer of 310 mg/L after 7 days. Other on-line data (i.e., pH, oxygen uptake rate, and CO2 evolution rate) and off-line data (i.e., analog production, glucose utilization, ammonium production, and dry cell weight) at the 15,000 L scale also tracked similarly to the smaller scale, demonstrating successful fermentation scale-up.

摘要

一种产生诺卡硫霉素类抗菌化合物的苛求无枝酸菌培养物被扩大到15000升的工作体积。进行了较低体积的中试发酵(600升、900升和1500升规模),以确定15000升规模下的工艺可行性。研究了接种量、叶轮尖端速度、体积气体流速、表观气体流速、背压和灭菌热应激的影响,以确定最佳的放大操作条件。接种量(6%对2%体积)和培养基灭菌(R₀为68对92分钟⁻¹)对生产率或效价没有影响,较高的叶轮尖端速度(2.1对2.9米/秒)有轻微影响(降低20%)。相比之下,较高的背压,包括在15000升规模下增加的压头压力(1.2对0.7千克/平方厘米)和低气体流速(0.25对0.8体积/体积·分钟),似乎存在问题(降低40 - 50%)。尾气中高二氧化碳水平可能是观察到生产率较低的原因。因此,将这种25倍放大(600 - 15000升)的空气流速控制为与可接受的较小规模批次的尾气二氧化碳曲线相匹配,以将水平维持在0.5%以下。15000升规模的发酵在7天后达到了预期的诺卡硫霉素I效价310毫克/升。15000升规模下的其他在线数据(即pH值、氧气摄取率和二氧化碳释放率)和离线数据(即类似物产量、葡萄糖利用、铵产量和干细胞重量)也与较小规模相似,表明发酵放大成功。

相似文献

1
Actinomycetes scale-up for the production of the antibacterial, nocathiacin.放线菌扩大培养以生产抗菌药物诺卡硫辛。
Biotechnol Prog. 2009 Jan-Feb;25(1):176-88. doi: 10.1002/btpr.122.
2
Pilot-scale process development and scale up for antifungal production.中试规模的抗真菌剂生产工艺开发与放大
Bioprocess Biosyst Eng. 2009 Jun;32(4):443-58. doi: 10.1007/s00449-008-0264-y. Epub 2008 Oct 14.
3
Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis.东方拟无枝酸菌生产万古霉素的培养条件优化及中试和工业化规模放大
Appl Microbiol Biotechnol. 2007 Dec;77(4):789-95. doi: 10.1007/s00253-007-1221-4. Epub 2007 Oct 16.
4
Quantification of power consumption and oxygen transfer characteristics of a stirred miniature bioreactor for predictive fermentation scale-up.用于预测发酵放大的搅拌式微型生物反应器的功耗和氧传递特性的量化
Biotechnol Bioeng. 2008 Aug 15;100(6):1144-55. doi: 10.1002/bit.21852.
5
Optimization of culture conditions and scale-up to plant scales for teicoplanin production by Actinoplanes teichomyceticus.通过游动放线菌优化替考拉宁生产的培养条件并扩大至工厂规模。
Appl Microbiol Biotechnol. 2008 Aug;80(1):21-7. doi: 10.1007/s00253-008-1530-2. Epub 2008 Jun 10.
6
Effects of increased impeller power in a production-scale Aspergillus oryzae fermentation.生产规模米曲霉发酵中叶轮功率增加的影响
Biotechnol Prog. 2002 May-Jun;18(3):437-44. doi: 10.1021/bp020023c.
7
Optimization of critical medium components for enhancing antibacterial thiopeptide nocathiacin I production with significantly improved quality.
Chin J Nat Med. 2017 Apr;15(4):292-300. doi: 10.1016/S1875-5364(17)30047-X.
8
Optimization of culture conditions and scale-up to pilot and plant scales for coenzyme Q10 production by Agrobacterium tumefaciens.根癌土壤杆菌生产辅酶Q10的培养条件优化及中试和工业化规模放大
Appl Microbiol Biotechnol. 2007 Apr;74(5):974-80. doi: 10.1007/s00253-006-0744-4. Epub 2006 Nov 24.
9
High-titer production of astaxanthin by the semi-industrial fermentation of Xanthophyllomyces dendrorhous.利用雨生红球藻进行半工业发酵生产虾青素。
J Biotechnol. 2010 Jul 20;148(2-3):144-6. doi: 10.1016/j.jbiotec.2010.05.004. Epub 2010 May 25.
10
Scale-up methodologies for Escherichia coli and yeast fermentation processes.大肠杆菌和酵母发酵过程的放大方法。
J Biosci Bioeng. 2004;97(6):347-64. doi: 10.1016/S1389-1723(04)70218-2.